-
1 Comment
Fuso Pharmaceutical Industries,Ltd is currently in a long term downtrend where the price is trading 15.3% below its 200 day moving average.
From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.5.
Fuso Pharmaceutical Industries,Ltd's total revenue rose by 5.8% to $13B since the same quarter in the previous year.
Its net income has increased by 33.2% to $377M since the same quarter in the previous year.
Based on the above factors, Fuso Pharmaceutical Industries,Ltd gets an overall score of 3/5.
| CurrencyCode | JPY |
|---|---|
| Sector | Healthcare |
| Exchange | TSE |
| Industry | Drug Manufacturers - Specialty & Generic |
| ISIN | JP3823600006 |
| PE Ratio | 8.92 |
|---|---|
| Target Price | None |
| Dividend Yield | 3.5% |
| Market Cap | 20B |
| Beta | 0.31 |
Fuso Pharmaceutical Industries,Ltd. manufactures and sells pharmaceuticals and medical equipment in Japan. The company offers injectables, infusions, and dialysis agents for artificial kidneys, as well as medical equipment and devices. It also engages in the contract manufacturing of drugs; and real estate leasing businesses. The company was incorporated in 1937 and is headquartered in Osaka, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 4538.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
